{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:07:19Z","timestamp":1786997239861,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T00:00:00Z","timestamp":1749340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016056"],"award-info":[{"award-number":["P30 CA016056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001320","name":"Roswell Park Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA016056"],"award-info":[{"award-number":["P30 CA016056"]}],"id":[{"id":"10.13039\/100001320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.suronc.2025.102243","type":"journal-article","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T18:27:46Z","timestamp":1749320866000},"page":"102243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["A phase 1 study of intra-arterial CBL0137 in extremity melanomas and sarcomas"],"prefix":"10.1016","volume":"61","author":[{"given":"Joseph J.","family":"Skitzki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John M.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla","family":"Catalfamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garin","family":"Tomaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Petroziello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Purmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina V.","family":"Gurova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei V.","family":"Gudkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suronc.2025.102243_bib1","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.soc.2008.04.005","article-title":"Isolated limb perfusion for melanoma","volume":"17","author":"Kroon","year":"2008","journal-title":"Surg. Oncol. Clin."},{"key":"10.1016\/j.suronc.2025.102243_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.108050","article-title":"Technical considerations for isolated limb perfusion: a consensus paper","volume":"50","author":"Hayes","year":"2024","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib3","doi-asserted-by":"crossref","first-page":"9272","DOI":"10.1245\/s10434-024-16159-y","article-title":"Isolated limb infusion for limb-threatening sarcomas","volume":"31","author":"Aflatooni","year":"2024","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib4","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1245\/s10434-019-07288-w","article-title":"Long-term oncologic outcomes after isolated limb infusion for locoregionally metastatic melanoma: an international multicenter analysis","volume":"26","author":"Miura","year":"2019","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib5","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1245\/s10434-020-09051-y","article-title":"Oncologic outcomes after isolated limb infusion for advanced melanoma: an international comparison of the procedure and outcomes between the United States and Australia","volume":"27","author":"Carr","year":"2020","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib6","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1245\/s10434-017-6109-7","article-title":"Isolated limb perfusion and infusion for extremity soft tissue sarcoma: a contemporary systematic review and meta-analysis","volume":"24","author":"Neuwirth","year":"2017","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","article-title":"Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit","volume":"148","author":"Creech","year":"1958","journal-title":"Ann. Surg."},{"key":"10.1016\/j.suronc.2025.102243_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<238::AID-SSU8>3.0.CO;2-9","article-title":"Isolated limb infusion with cytotoxic agents: a simple alternative to isolated limb perfusion","volume":"14","author":"Thompson","year":"1998","journal-title":"Semin. Surg. Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib9","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","article-title":"Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions","volume":"18","author":"Wieberdink","year":"1982","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35636","article-title":"A comparison of isolated limb infusion\/perfusion, immune checkpoint inhibitors, and intralesional therapy as first-line treatment for patients with melanoma in-transit metastases","volume":"131","author":"DePalo","year":"2025","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2025.102243_bib11","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/cancers7030830","article-title":"The role of regional therapies for in-transit melanoma in the era of improved systemic options","volume":"7","author":"Gabriel","year":"2015","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.suronc.2025.102243_bib12","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.14694\/EdBook_AM.2015.35.e528","article-title":"Perfusion and infusion for melanoma in-transit metastases in the era of effective systemic therapy","author":"Grunhagen","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.suronc.2025.102243_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jso.23502","article-title":"Isolated limb infusion as a model to test new agents to treat metastatic melanoma","volume":"109","author":"Lidsky","year":"2014","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jss.2012.03.032","article-title":"A novel mouse model of isolated limb perfusion for extremity melanoma","volume":"178","author":"Kim","year":"2012","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.suronc.2025.102243_bib15","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1158\/0008-5472.CAN-15-2764","article-title":"Preclinical validation of a single-treatment infusion modality that can eradicate extremity melanomas","volume":"76","author":"Kim","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.suronc.2025.102243_bib16","series-title":"ASCO Annual Meeting I, City","article-title":"Results of a completed phase I trial of CBL0137 administered intravenously (IV) to patients (Pts) with advanced solid tumors","author":"Sarantopoulos","year":"2020"},{"key":"10.1016\/j.suronc.2025.102243_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002530","article-title":"Curaxins: anticancer compounds that simultaneously suppress NF-kappaB and activate p53 by targeting FACT","volume":"3","author":"Gasparian","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.suronc.2025.102243_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.celrep.2013.06.013","article-title":"Facilitates chromatin transcription complex is an \"accelerator\" of tumor transformation and potential marker and target of aggressive cancers","volume":"4","author":"Garcia","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.suronc.2025.102243_bib19","article-title":"Image-based quantitative single-cell method showed increase of global chromatin accessibility in tumor compared to normal cells","author":"Commane","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.suronc.2025.102243_bib20","series-title":"Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers","author":"Usfd","year":"2005"},{"key":"10.1016\/j.suronc.2025.102243_bib21","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.yrtph.2015.01.014","article-title":"An FDA oncology analysis of antibody-drug conjugates","volume":"71","author":"Saber","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.suronc.2025.102243_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.soc.2020.08.007","article-title":"Hepatic perfusion for diffuse metastatic cancer to the liver: open and percutaneous techniques","volume":"30","author":"Alexander","year":"2021","journal-title":"Surg. Oncol. Clin."},{"key":"10.1016\/j.suronc.2025.102243_bib23","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1245\/s10434-007-9652-9","article-title":"Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum","volume":"15","author":"Wanebo","year":"2008","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2025.102243_bib24","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","article-title":"ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis","volume":"606","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.suronc.2025.102243_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116765","article-title":"The anti-cancer drug candidate CBL0137 induced necroptosis via forming left-handed Z-DNA and its binding protein ZBP1 in liver cells","volume":"482","author":"Li","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.suronc.2025.102243_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213711","article-title":"Enhancing anti-PD-1 immunotherapy by targeting MDSCs via hepatic arterial infusion in breast cancer liver metastases","volume":"16","author":"Kim","year":"2024","journal-title":"Cancers (Basel)"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740425000581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740425000581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:57:53Z","timestamp":1762343873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740425000581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":26,"alternative-id":["S0960740425000581"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2025.102243","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 1 study of intra-arterial CBL0137 in extremity melanomas and sarcomas","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2025.102243","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102243"}}